Evidence map›Paper›PMID 37907520›Full record

ArticleNature communications2023

Inferring bacterial transmission dynamics using deep sequencing genomic surveillance data.

Madikay Senghore, Hannah Read, Priyali Oza, Sarah Johnson, Hemanoel Passarelli-Araujo, Bradford P Taylor, Stephen Ashley, Alex Grey, Alanna Callendrello, Robyn Lee and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Exploring clonality ofMicrobiology spectrum · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 5 countries.

Madikay Senghore *Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA. msenghore@hsph.harvard.edu.ORCID 0000-0002-4303-6236
Hannah Read *Bioluminescent Superbugs Lab, Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.ORCID 0000-0002-9540-5224
Priyali OzaBioluminescent Superbugs Lab, Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.ORCID 0000-0002-3721-1261
Sarah JohnsonBioluminescent Superbugs Lab, Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.
Hemanoel Passarelli-AraujoCenter for Communicable Disease Dynamics, Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA.
Bradford P TaylorCenter for Communicable Disease Dynamics, Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA.
Stephen AshleyBioluminescent Superbugs Lab, Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.
Alex GreyBioluminescent Superbugs Lab, Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.ORCID 0000-0001-9659-6408
Alanna CallendrelloCenter for Communicable Disease Dynamics, Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA.
Robyn LeeCenter for Communicable Disease Dynamics, Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA.
Matthew R GoddardSchool of Biological Sciences, University of Auckland, Auckland, New Zealand.ORCID 0000-0002-7482-4438
Thomas LumleyDepartment of Statistics, University of Auckland, Auckland, New Zealand.
William P HanageCenter for Communicable Disease Dynamics, Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA.ORCID 0000-0002-6319-7336
Siouxsie WilesBioluminescent Superbugs Lab, Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand. s.wiles@auckland.ac.nz.ORCID 0000-0002-0467-0015
University of Auckland · NZCenter for Disease Dynamics, Economics & Policy · USUniversidade Federal de Minas Gerais · BR

Funding

Deep sequencing of pathogens to precisely define transmission networks using rare variantsR01AI128344 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI HANAGE, WILLIAM · 2017 to 2021
$3.4M
NIAID NIH HHS R01 AI128344
6 · The paper itself

Abstract

Identifying and interrupting transmission chains is important for controlling infectious diseases. One way to identify transmission pairs - two hosts in which infection was transmitted from one to the other - is using the variation of the pathogen within each single host (within-host variation). However, the role of such variation in transmission is understudied due to a lack of experimental and clinical datasets that capture pathogen diversity in both donor and recipient hosts. In this work, we assess the utility of deep-sequenced genomic surveillance (where genomic regions are sequenced hundreds to thousands of times) using a mouse transmission model involving controlled spread of the pathogenic bacterium Citrobacter rodentium from infected to naïve female animals. We observe that within-host single nucleotide variants (iSNVs) are maintained over multiple transmission steps and present a model for inferring the likelihood that a given pair of sequenced samples are linked by transmission. In this work we show that, beyond the presence and absence of within-host variants, differences arising in the relative abundance of iSNVs (allelic frequency) can infer transmission pairs more precisely. Our approach further highlights the critical role bottlenecks play in reserving the within-host diversity during transmission.

Indexed as

Genetic VariationGenomicsAnimalsBacteriaFemaleGene FrequencyHigh-Throughput Nucleotide Sequencing

Identifiers

PMID37907520
PMCPMC10618251
OpenAlexW4388047407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.